Clinical Study of Acupuncture in the Treatment of Diabetic Peripheral Neuropathy
1 other identifier
interventional
118
1 country
1
Brief Summary
Diabetic peripheral neuropathy (DPN) is the most common chronic complication of diabetes mellitus that has a considerable impact on quality of life, but there are few effective therapeutic strategies. The aim of this trial is to determine the efficacy and safety of manual acupuncture (MA) versus sham acupuncture (SA) for DPN.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 24, 2023
CompletedFirst Posted
Study publicly available on registry
May 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedMay 18, 2023
May 1, 2023
3.3 years
March 24, 2023
May 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peroneal Motor Nerve Conduction Velocity
Measurement by electromyography
12 week
Secondary Outcomes (6)
Glycated hemoglobin (HbA1c)
12 week
Fasting plasma glucose (FPG)
12 week
2-h postprandial blood glucose (2hPG)
12 week
Michigan Neuropathy Screening Instrument (MNSI) score
12 week
Quality of life (QoL)
12 week
- +1 more secondary outcomes
Study Arms (2)
Manual Acupuncture Group
EXPERIMENTALTreatment will be performed by licensed acupuncturists who have at least 5 years of experience in acupuncture. All the acupuncturists will be trained how to locate acupoints, puncture, and manipulate needles before trials.
Sham Acupuncture
SHAM COMPARATORThe procedure and duration of treatment in the sham acupuncture group will be identical in the MA group except the needles are blunt tip and there will be no skin penetration and needle manipulation for De qi.
Interventions
The obligatory acupoints include Zhongwan (CV12), bilateral Weiwanxiashu (EX-B3), bilateral Ganshu (BL18), bilateral Pishu (BL20), bilateral Shenshu (BL23), bilateral Zusanli (ST36), bilateral Yanglingquan (GB34), bilateral Sanyinjiao (SP6), bilateral Taixi (KI3), and Bafeng (EX-LE10). Additional acupoints Baxie (EX-UE9) will be added when patients' symptoms appear not only in the lower limbs but also in the upper limbs. After skin disinfection, disposable, stainless steel acupuncture needles will be inserted into the skin of acupoint (approximately 10-20 mm depth), and then manipulations of twirling, lifting, and thrusting will be performed on all needles for at least 10 s to reach De qi (a compositional sensation including soreness, numbness, distention, and heaviness), which is believed to be an essential component for acupuncture efficacy. Needles will be retained in these acupoints for 20 min.
Patients in the SA group will receive sham acupuncture. The procedure and duration of treatment in the SA group will be identical in the MA group except the needles are blunt tip and there will be no skin penetration and needle manipulation for De qi.
Eligibility Criteria
You may qualify if:
- \. Aged 18-75 years (either sex)
- Symmetric and predominantly sensory, starting from the lower limbs distally and gradually spreading proximally in a glove-and-stocking distribution.
- Ability to understand study procedures and willingness to comply with them for the entire period of study.
- Written informed consent
You may not qualify if:
- PN caused by conditions other than diabetes (e.g.,alcohol abuse, chemotherapy, hereditary causes, chronic inflammatory, or idiopathic PN)
- Psychiatric illnesses other than mild depression.
- Severe or unstable cardiovascular, liver, kidney, respiratory, or hematological disorders.
- Received acupuncture treatment in the last 3 months.
- Pregnant or lactating women.
- Research unit personnel directly related to the study and their immediate family members.
- Incapable of giving informed consent or following the study instructions due to language disturbances, serious cognitive deficits, or lack of time.
- Currently participating in other clinical trials.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LongHua Hospital Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, 200032, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jian Pei
Shanghai University of Traditional Chinese Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2023
First Posted
May 18, 2023
Study Start
September 1, 2021
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
May 18, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share